The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury

Journal of Autoimmunity

Volumn 53, Issue C, 2014, Pages 55-66

  Zhang, Haiyan ^a   Liu, Yuan ^a   Bian, Zhaolian ^a   Huang, Shanshan ^a   Han, Xiaofeng ^a   You, Zhengrui ^a   Wang, Qixia ^a   Qiu, Dekai ^a   Miao, Qi ^a   Peng, Yanshen ^a   Li, Xiaoying ^b   Invernizzi, Pietro ^c   Ma, Xiong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Autoimmunity; FXR activation; Lymphoid subpopulations; Myeloid derived suppressor cells

Indexed keywords

CONCANAVALIN A; FARNESOID X RECEPTOR; ALPHA-GALACTOSYLCERAMIDE; CALGRANULIN A; CD11B ANTIGEN; CELL RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; GALACTOSYLCERAMIDE; IMMUNOGLOBULIN RECEPTOR; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; MITOGENIC AGENT; PIRB PROTEIN, MOUSE; S100A8 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE LIVER DISEASE; BONE MARROW CELL; CELL FUNCTION; CELL POPULATION; CELL TRANSFER; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; LIVER CELL; MALE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR UPREGULATION; SUPPRESSOR CELL; WILD TYPE; ANIMAL; AUTOIMMUNE HEPATITIS; GENETICS; IMMUNOLOGY; LIVER; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; CALGRANULIN A; CONCANAVALIN A; GALACTOSYLCERAMIDES; HEPATITIS, AUTOIMMUNE; LIVER; MICE; MICE, TRANSGENIC; MITOGENS; MYELOID CELLS; PROMOTER REGIONS, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, IMMUNOLOGIC;

EID: 84926408803     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.02.010     Document Type: Article

References (36)

1. Wang Y.D., Chen W.D., Wang M., Yu D., Forman B.M., Huang W. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology 2008, 48:1632-1643.
2. Schote A.B., Turner J.D., Schiltz J., Muller C.P. Nuclear receptors in human immune cells: expression and correlations. Mol Immunol 2007, 44:1436-1445.
3. Inagaki T., Moschetta A., Lee Y.K., Peng L., Zhao G., Downes M., et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A 2006, 103:3920-3925.
4. Ilkovitch D., Lopez D.M. The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. Cancer Res 2009, 69:5514-5521.
5. Cripps J.G., Wang J., Maria A., Blumenthal I., Gorham J.D. Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver. Hepatology 2010, 52:1350-1359.
6. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9:162-174.
7. Ostrand-Rosenberg S., Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. JImmunol 2009, 182:4499-4506.
8. Movahedi K., Guilliams M., Van den Bossche J., Van den Bergh R., Gysemans C., Beschin A., et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008, 111:4233-4244.
9. Dietlin T.A., Hofman F.M., Lund B.T., Gilmore W., Stohlman S.A., van der Veen R.C. Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion. JLeukoc Biol 2007, 81:1205-1212.
10. Hoechst B., Voigtlaender T., Ormandy L., Gamrekelashvili J., Zhao F., Wedemeyer H., et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 2009, 50:799-807.
11. Lee H., Hubbert M.L., Osborne T.F., Woodford K., Zerangue N., Edwards P.A. Regulation of the sodium/sulfate co-transporter by farnesoid X receptor alpha. JBiol Chem 2007, 282:21653-21661.
12. Liu Y., Binz J., Numerick M.J., Dennis S., Luo G., Desai B., et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. JClin Invest 2003, 112:1678-1687.
13. Bian Z., Peng Y., You Z., Wang Q., Miao Q., Liu Y., et al. CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice. JLipid Res 2013, 54:44-54.
14. Tang Y., Bian Z., Zhao L., Liu Y., Liang S., Wang Q., et al. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease. Clin Exp Immunol 2011, 166:281-290.
15. Sarra M., Cupi M.L., Bernardini R., Ronchetti G., Monteleone I., Ranalli M., et al. IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism. Hepatology 2013, 58:1436-1450.
16. Rossner S., Voigtlander C., Wiethe C., Hanig J., Seifarth C., Lutz M.B. Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production invitro. Eur J Immunol 2005, 35:3533-3544.
17. Kawamoto T., Shimizu M. Amethod for preparing 2- to 50-micron-thick fresh-frozen sections of large samples and undecalcified hard tissues. Histochem Cell Biol 2000, 113:331-339.
18. Onori P., Alvaro D., Floreani A.R., Mancino M.G., Franchitto A., Guido M., et al. Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis. JHistochem Cytochem 2007, 55:327-334.
19. Youn J.I., Nagaraj S., Collazo M., Gabrilovich D.I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. JImmunol 2008, 181:5791-5802.
20. You Z., Wang Q., Bian Z., Liu Y., Han X., Peng Y., et al. The immunopathology of liver granulomas in primary biliary cirrhosis. JAutoimmun 2012, 39:216-221.
21. Ma G., Pan P.Y., Eisenstein S., Divino C.M., Lowell C.A., Takai T., et al. Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 2011, 34:385-395.
22. Haverkamp J.M., Crist S.A., Elzey B.D., Cimen C., Ratliff T.L. Invivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. Eur J Immunol 2011, 41:749-759.
23. Matsushita H., Endo S., Kobayashi E., Sakamoto Y., Kobayashi K., Kitaguchi K., et al. Differential but competitive binding of Nogo protein and class i major histocompatibility complex (MHCI) to the PIR-B ectodomain provides an inhibition of cells. JBiol Chem 2011, 286:25739-25747.
24. Endo S., Sakamoto Y., Kobayashi E., Nakamura A., Takai T. Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. Proc Natl Acad Sci U S A 2008, 105:14515-14520.
25. Mitsuhashi Y., Nakamura A., Endo S., Takeda K., Yabe-Wada T., Nukiwa T., et al. Regulation of plasmacytoid dendritic cell responses by PIR-B. Blood 2012, 120:3256-3259.
26. Munitz A., Cole E.T., Beichler A., Groschwitz K., Ahrens R., Steinbrecher K., et al. Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis. Gastroenterology 2010, 139:530-541.
27. Arita K., Endo S., Kaifu T., Kitaguchi K., Nakamura A., Ohmori H., et al. Transcriptional activation of the Pirb gene in B cells by PU.1 and Runx3. JImmunol 2011, 186:7050-7059.
28. Bunt S.K., Sinha P., Clements V.K., Leips J., Ostrand-Rosenberg S. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. JImmunol 2006, 176:284-290.
29. Sinha P., Clements V.K., Fulton A.M., Ostrand-Rosenberg S. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res 2007, 67:4507-4513.
30. Sinha P., Okoro C., Foell D., Freeze H.H., Ostrand-Rosenberg S., Srikrishna G. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. JImmunol 2008, 181:4666-4675.
31. Bunt S.K., Yang L., Sinha P., Clements V.K., Leips J., Ostrand-Rosenberg S. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res 2007, 67:10019-10026.
32. Hoechst B., Ormandy L.A., Ballmaier M., Lehner F., Kruger C., Manns M.P., et al. Anew population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008, 135:234-243.
33. Sander L.E., Sackett S.D., Dierssen U., Beraza N., Linke R.P., Muller M., et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. JExp Med 2010, 207:1453-1464.
34. Chou H.S., Hsieh C.C., Yang H.R., Wang L., Arakawa Y., Brown K., et al. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology 2011, 53:1007-1019.
35. Hegde V.L., Nagarkatti P.S., Nagarkatti M. Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. PloS One 2011, 6:e18281.
36. Suh Y.G., Kim J.K., Byun J.S., Yi H.S., Lee Y.S., Eun H.S., et al. CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice. Hepatology 2012, 56:1902-1912.